Updated on  June 26, 2024
4 min read

Will Stem Cell Therapy Work for Eye Diseases?

6 sources cited
Vision Center is funded by our readers. We may earn commissions if you purchase something via one of our links.

Imagine tiny building blocks within your body that can transform into different types of cells, offering the potential to repair damaged tissues and restore lost function.

These remarkable building blocks are called stem cells, and they are revolutionizing the field of regenerative medicine, particularly in treating eye diseases.

In this article, we’ll discuss the fascinating topic of stem cells, their role in eye care, and the advancements that promise to restore vision for countless people.

How Can Stem Cell Therapy Help Retinal Diseases?

Diseases like age-related macular degeneration (AMD) happen because some of our eye cells break down. The idea is to replace them with healthy ones made from stem cells.

One way to do this is through direct replacement. Make a stem cell, turn it into that exact eye cell a person needs, and replace the old one that died.

In other cases, stem cells act as a helping hand. They release chemicals that help neighboring cells within the retina repair themselves and maintain their function.

Certain stem cells can also regulate the immune system, reducing inflammation and potentially slowing the progression of eye diseases where inflammation plays a role.

What Are the Different Types of Stem Cells?

Each type of stem cell has unique advantages and challenges:

  • Adult (somatic). Found in the body after development, capable of self-renewal and generating the specific tissue’s cell types. They’re easier to obtain, but their differentiation potential is more limited. Research is primarily focused on their ability to support and protect existing cells in the eye.
  • Induced Pluripotent (iPSCs). Adult cells are reprogrammed to an embryonic stem cell-like state, capable of becoming any cell type. These cells combine the flexibility of embryonic stem cells with the advantage of being derived from the patient’s own cells, reducing the risk of rejection.
  • Embryonic stem cells. These offer great flexibility in terms of the types of cells they can become, but they are difficult to obtain and raise ethical concerns for some individuals.

Stem cells can also be classified based on their differentiation potential:

  • Totipotent. Can become any cell type, including placental cells.
  • Pluripotent. Can become nearly any cell type, including embryonic stem cells.
  • Multipotent. Can develop into a limited range of related cell types.
  • Oligopotent. Can develop into a few specific cell types.
  • Unipotent. Can only produce one cell type.

What are the Studies Showing?

There is a lot of research ongoing regarding stem cell therapy. So far, most trials have shown that these cells are generally safe to put in the eye. 

There are promising results in the field of regenerative medicine, especially for conditions like age-related macular degeneration (AMD). While this isn’t a complete cure, it’s a significant step forward and offers hope for future treatments for vision loss.

Research on mesenchymal stem cells is also showing that they can be used for many more diseases. These cells could be a tool to calm inflammation throughout the body.

Challenges in Stem Cell Therapy for Eye Diseases

Although stem cell therapy seems promising, there are still a few challenges to overcome:

Immune Rejection

The immune system plays a crucial role in protecting the body. However, it can sometimes mistake transplanted stem cells for foreign invaders and attack them. 

To avoid immune rejection, the best option is to use your cells as the starting point (iPSCs). That way, the immune system doesn’t really see them as anything new.

Researchers are also working on editing stem cells to make them less visible to the immune system or to temporarily calm those immune cells down with medication.

Cell Survival and Integration

Transplanted stem cells require specific support for survival and integration into the retinal tissue. There are two approaches to this:

  • Exogenous Neurotrophic Factor Delivery. This involves supplementing the transplanted stem cells with essential neurotrophic factors. It’s similar to providing a “care package” to help them establish themselves in the new environment.
  • Endogenous Neurotrophic Factor Production. Genetically modifying stem cells to produce their own neurotrophic factors can help researchers enhance the cells’ survival and integration capabilities.

Precise Targeting and Integration

It’s not just about the cells surviving, they need to connect and work in the retina. This can be tricky, but scientists are looking for better ways to inject the cells exactly where they’re needed in the eye.

Specialized biomaterials, similar to gels, are also being developed to help transplanted stem cells adhere to the desired location in the eye.

What to Expect Moving Forward

Overcoming any one of these obstacles we mentioned above would be a win. Fortunately, researchers are now working to combine the best solutions. 

They’re currently working on making stem cell therapy more personalized. Cells made from your own body, pre-loaded with survival factors, are delivered to the exact spot in your eye where they’re needed.

Smarter stem cell therapy systems are also being developed. Combined therapies could involve using stem cells alongside specific drugs and specialized gels to create an ideal environment for cell growth and integration. This can potentially lead to better outcomes than using any single component alone.

Stem cell therapy is absolutely cutting-edge. If you or a loved one are exploring this, the most important thing is finding a doctor and research facility that is realistic about the risks, benefits, and what’s still unknown.

Updated on  June 26, 2024
6 sources cited
Updated on  June 26, 2024
  1. “Stem Cell Basics.” National Institutes of Health. 
  2. Christelle M, Lise M, & Ben M’Barek K. “Challenges of cell therapies for retinal diseases.” International Review of Neurobiology, 2021.
  3. Niu et al. “Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges.” Advances in Ophthalmology Practice and Research, 2024.
  4. Öner A. “Stem Cell Treatment in Retinal Diseases: Recent Developments.” Turkish Journal of Ophthalmology, 2018.
  5. Mead et al. “Stem cell treatment of degenerative eye disease.” Stem Cell Research, 2015.
  6. Chen et al. “Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis.” Stem Cell Res Ther, 2023.
The information provided on VisionCenter.org should not be used in place of actual information provided by a doctor or a specialist.